A Study of ZN-c5 in Subjects With Breast Cancer

NCT03560531 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: ZN-c5
DRUG: Palbociclib

Sponsor

Zeno Alpha Inc.